I am pro the management team. I feel this will be
Post# of 148331
As for catalysts that could happen before September’s annual meeting. LH’s phase 2 could boost the SP. Interim Order filed and accepted by Canada. Another little positive SP bump, CSP with sales in any foreign countries that want to use Leronlimab as a trial at their cost of our sales generating some revenue.
The big one that locks Nader and Board in... is if they get a Interim results from the Brazil trial by late August that gives us EUA’s everywhere. So like CDiddy said... performance is everything and the chances are out there for us to judge. I would vote our management back in with minimal catalysts if the one that happens... is the interim results from the Brazil trial shows good because everything really starts rolling from that.
I think the moronic 5%er’s are crazy and I hope they don’t get anywhere. That everything goes as planned and they are laughed out of the room. It really has to be some other competition in another Pharma driving this BS. We have constant attacks from paid people on this board and all boards. It’s a very organized thing to do this. Sounds of big money Pharma politics to me. Do they just want a management change or do they want to destroy CYDY and remove the competition we will be? That’s the real question!